Iriagbonese Nosakhare is a Plano, Texas based nurse practitioner. Active license number of Iriagbonese Nosakhare is AP138374 for Acute Care in Texas. Her current practice location is 3901 W 15th St, Plano. Patients can reach her at 972-596-6800 and her NPI number (Unique professional ID assigned by NPPES) is 1396214383. Iriagbonese Nosakhare has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Iriagbonese Nosakhare speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1396214383
NPI Enumeration Date:
19 Nov, 2018
NPI Last Update On:
04 Apr, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Iriagbonese Nosakhare are as mentioned below.
License Number
Specialization
State
Status
AP138374
Acute Care
Texas
Primary
842563
Registered Nurse
Texas
Secondary
AP138374
Orthopaedic Surgery
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Iriagbonese Nosakhare 3901 W 15th St, Plano, Texas
Zip:
75075-7738
Patients can reach Iriagbonese Nosakhare at 3901 W 15th St, Plano, Texas or can call to book an appointment on 972-596-6800.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.